The Hydration Pharmaceuticals Company Limited (HPC.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.04 Million | 9.09 Million | 5.91 Million | 3.75 Million | 2.96 Million | 4.16 Million |
| Cost of Revenue | 4.64 Million | 4.4 Million | 3.33 Million | 2.42 Million | 1.58 Million | 4.23 Million |
| Gross Profit | 5.39 Million | 4.69 Million | 2.58 Million | 1.33 Million | 1.37 Million | -75.26 Thousand |
| Operating Expenses | 5.39 Million | 15.39 Million | 9.31 Million | 2.06 Million | 4.79 Million | 9.5 Million |
| Selling, General and Administrative Expenses | 13.13 Million | 15.39 Million | 9.31 Million | 4.61 Million | 4.76 Million | 9.1 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 185.81 Thousand | 1.41 Million | - | - | - |
| Cost and Expenses | 17.78 Million | 19.8 Million | 12.65 Million | 4.48 Million | 6.38 Million | 13.74 Million |
| Operating Income | -7.74 Million | -10.51 Million | -5.32 Million | -3.29 Million | -3.4 Million | -9.25 Million |
| Interest Expense | 642.9 Thousand | 91.2 Thousand | 3.63 Million | - | - | - |
| Income Tax Expense | - | 273.68 Thousand | 5.05 Million | - | - | - |
| Earnings before Tax | -8.1 Million | -10.6 Million | -8.96 Million | -743.66 Thousand | -3.43 Million | -9.6 Million |
| Net Income | -8.1 Million | -10.6 Million | -8.96 Million | -743.66 Thousand | -3.43 Million | -9.6 Million |
| Earnings Per Share Basic | -0.04 | -0.07 | -0.12 | -0.01 | -0.06 | -0.17 |
| Earnings Per Share Diluted | -0.04 | -0.07 | -0.12 | -0.01 | -0.06 | -0.17 |
| Weighted Average Shares Outstanding | 195.12 Million | 162.68 Million | 75.53 Million | 64.92 Million | 56.76 Million | 56.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 195.12 Million | 162.68 Million | 75.53 Million | 64.92 Million | 56.76 Million | 56.76 Million |
| Gross Margin | 0.54 | 0.52 | 0.44 | 0.36 | 0.46 | -0.02 |
| EBIT Margin | -0.74 | -1.16 | -0.90 | -0.87 | -1.14 | -2.21 |
| Profit Margin | -0.81 | -1.17 | -1.51 | -0.20 | -1.16 | -2.31 |
| EBITDA | -7.45 Million | -10.51 Million | -6.08 Million | -3.27 Million | -3.38 Million | -9.18 Million |
| Earnings Before Tax Margin | -0.77 | -1.16 | -0.90 | -0.88 | -1.15 | -2.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.48 Million | 2.48 Million | 2.36 Million | 10.04 Million | 2.36 Million | 2.65 Million |
| Cost of Revenue | 1.17 Million | 1.17 Million | 962.69 Thousand | 4.64 Million | 962.69 Thousand | 1.36 Million |
| Gross Profit | 1.31 Million | 1.31 Million | 1.4 Million | 5.39 Million | 1.4 Million | 1.29 Million |
| Operating Expenses | 2.56 Million | 2.56 Million | 3.28 Million | 13.13 Million | 3.53 Million | 2.89 Million |
| Selling, General and Administrative Expenses | 2.56 Million | 2.56 Million | 3.28 Million | - | 3.28 Million | 3.28 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | 282.4 Thousand | - | - |
| Cost and Expenses | 3.73 Million | 3.73 Million | 4.24 Million | 17.5 Million | 4.49 Million | 4.25 Million |
| Operating Income | -1.25 Million | -1.25 Million | -1.87 Million | -7.74 Million | -1.87 Million | -1.99 Million |
| Interest Expense | - | - | - | 642.9 Thousand | - | - |
| Income Tax Expense | - | - | -411.04 Thousand | -360.49 Thousand | -411.04 Thousand | 230.8 Thousand |
| Earnings before Tax | -1.55 Million | -1.55 Million | -2.28 Million | -8.1 Million | -2.28 Million | -1.76 Million |
| Net Income | -1.55 Million | -1.55 Million | -2.28 Million | -8.1 Million | -2.28 Million | -1.76 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | - | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 276.29 Million | 276.29 Million | 214.49 Million | 195.12 Million | 214.49 Million | 163.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 276.28 Million | 276.28 Million | 226.43 Million | 195.12 Million | 226.43 Million | 163.82 Million |
| Gross Margin | 0.53 | 0.53 | 0.59 | 0.54 | 0.59 | 0.49 |
| EBIT Margin | -0.00 | -0.00 | -0.17 | - | -0.17 | 0.09 |
| Profit Margin | -0.63 | -0.63 | -0.97 | -0.81 | -0.97 | -0.67 |
| EBITDA | -1.00 | -1.00 | -411.04 Thousand | - | -411.04 Thousand | 230.8 Thousand |
| Earnings Before Tax Margin | -0.50 | -0.50 | -0.79 | -0.77 | -0.79 | -0.75 |
IPPE
1705
FRPT
8006
SARVESHWAR
B4B